Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +48.16%
#3 Velvet Velvet +44.46%
#4 Akedo Akedo +40.57%
#5 Black Phoenix Black Phoenix +33.98%
#6 Cross Cross +24.15%
#7 Cap Cap +20.35%
#8 DoubleZero DoubleZero +14.60%
#9 Tutorial Tutorial +11.59%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.77%
Coin of the day
Islamic Coin Islamic Coin
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Helyezés a részvények között #39467
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Részvényárfolyam
$0.11725176
Utolsó szinkronizálás: 2025-07-14
Piaci kapitalizáció
$481.50K
Változás (1 nap)
-0.20%
Változás (1 év)
0.00%
Ország
FR
Kereskedés PHAXIAM Therapeutics S.A. (PHXM)

Kategória

Healthcare
PHAXIAM Therapeutics S.A. (PHXM) P/S aránya
P/S arány ekkor: August 2026 TTM: 0.76
PHAXIAM Therapeutics S.A. legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi árbevétel aránya (P/S, TTM) 0.76. 2022 végén ez az arány 1.71 volt.
P/S arány története a(z) PHAXIAM Therapeutics S.A. esetén 2016 és 2026 között
P/S arány az év végén
Év P/S arány Változtassa meg
2026 (TTM) 0.76 -94.94%
2023 15.05 779.26%
2022 1.71 -85.75%
2021 12.01 -65.83%
2020 35.16 54.56%
2019 22.75 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
P/S arány hasonló vállalatoknál vagy versenytársaknál
Vállalat P/S arány P/S arány különbség Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 1,197.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 1,252.63%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 553.71%
BE